AI Verdict
RKT has stronger fundamentals based on our AI analysis.
RLAY vs RKT Fundamental Comparison
| Metric | RLAY | RKT |
|---|---|---|
| Revenue | $15.4M | $125.0M |
| Net Income | $-276.5M | $-68.0M |
| Net Margin | -1,800.6% | -54.4% |
| ROE | -48.8% | -0.3% |
| ROA | -44.5% | -0.1% |
| Current Ratio | 22.61x | N/A |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-1.61 | $-0.05 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLAY vs RKT: Frequently Asked Questions
Is RLAY or RKT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RKT has stronger fundamentals. RLAY is rated SELL (78% confidence) while RKT is rated SELL (84% confidence). This is not investment advice.
How does RLAY compare to RKT fundamentally?
Relay Therapeutics, Inc. has ROE of -48.8% vs Rocket Companies, Inc.'s -0.3%. Net margins are -1,800.6% vs -54.4% respectively.
Which stock pays higher dividends, RLAY or RKT?
RLAY has a dividend yield of N/A or no dividend while RKT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLAY or RKT for long term?
For long-term investing, consider that RLAY has SELL rating with 78% confidence, while RKT has SELL rating with 84% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLAY vs RKT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLAY vs RKT, the AI consensus favors RKT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.